Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4aa5 | NQB | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.676 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.652 | |
| 3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.649 | |
| 2qd9 | LGF | Mitogen-activated protein kinase 14 | / | 0.624 | |
| 4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.614 | |
| 3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.607 | |
| 3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.601 | |
| 2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.598 | |
| 3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.597 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.593 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.591 | |
| 3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.582 | |
| 3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.563 | |
| 3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.560 | |
| 3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.558 | |
| 2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.556 | |
| 3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.555 | |
| 3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.554 | |
| 4kin | 1M8 | Mitogen-activated protein kinase 14 | / | 0.551 | |
| 3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.550 | |
| 4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.545 | |
| 1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.544 | |
| 2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.543 | |
| 3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.543 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.542 | |
| 4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.541 | |
| 3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.537 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.534 | |
| 3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.530 | |
| 3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.526 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.521 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.519 | |
| 3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.517 | |
| 4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.516 | |
| 3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.510 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.506 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.504 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.498 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.497 | |
| 3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.492 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.489 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.484 | |
| 2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.484 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.483 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.480 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.479 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.474 | |
| 2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.472 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.471 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.470 | |
| 3fwf | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.470 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.468 | |
| 1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.466 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
| 3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.465 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.465 | |
| 2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.464 | |
| 5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.464 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.463 | |
| 3cpp | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.463 | |
| 3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.463 | |
| 1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.462 | |
| 4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.461 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.460 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.460 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
| 3bv3 | P39 | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
| 3gc7 | B45 | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 3mwu | BK3 | Calmodulin-domain protein kinase 1, putative | / | 0.456 | |
| 4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.456 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.455 | |
| 1bl6 | SB6 | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 2oor | NAD | NAD(P) transhydrogenase subunit alpha part 1 | 1.6.1.2 | 0.454 | |
| 3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.454 | |
| 4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.454 | |
| 4eh7 | 0OO | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.453 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.453 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.452 | |
| 4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.451 | |
| 2vyn | NAD | Glyceraldehyde-3-phosphate dehydrogenase A | / | 0.450 | |
| 4c8b | 0LI | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.450 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.449 | |
| 4h4z | FAD | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.449 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
| 3lxi | CAM | Cytochrome P450 | / | 0.448 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
| 2qbl | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.447 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.447 | |
| 3l63 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.447 | |
| 4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.447 | |
| 4l4f | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.447 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
| 2zax | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
| 3fwi | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
| 4kky | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
| 1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.445 | |
| 1dz6 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
| 2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.444 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.444 | |
| 1phe | PIY | Camphor 5-monooxygenase | 1.14.15.1 | 0.443 | |
| 1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.442 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.442 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.442 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.442 | |
| 4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.442 | |
| 1c3x | 8IG | Purine nucleoside phosphorylase | 2.4.2.1 | 0.441 | |
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 2a1m | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
| 3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.441 | |
| 3o8t | BMU | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3wrl | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.441 | |
| 4o2z | 046 | Mitogen-activated protein kinase | / | 0.441 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.441 | |
| 1ywn | LIF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.440 | |
| 4jdr | FAD | Dihydrolipoyl dehydrogenase | 1.8.1.4 | 0.440 |